AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglow 0.3 GM3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglow 0.3 GM3 Tablet SR

Diabetic patients may find relief with Glycemia Control 0.3 MG3 SR tablets, a dual-action anti-diabetic medication. This formulation is indicated for adult-onset type 2 diabetes management, effectively regulating blood glucose. Administer Glycemia Control 0.3 MG3 SR with meals, consistently at the same time daily for optimal results. Dosage is determined individually by your physician and may be adjusted based on glucose monitoring. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, Glycemia Control 0.3 MG3 SR is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular meals, carry readily available glucose sources (e.g., sugary snacks, juice), and limit alcohol consumption to mitigate this risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Glycemia Control 0.3 MG3 SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Voglow 0.3 GM3 Tablet SR

Managing type 2 diabetes

Major Benefits of Voglow 0.3 GM3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglow 0.3 GM3 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Voglow 0.3 GM3 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglow 0.3 GM3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Voglow 0.3 GM3 Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer on an empty stomach.

How Voglow 0.3 GM3 Tablet SR works:

Each Voglow 0.3 GM3 sustained-release tablet contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglow 0.3 GM3 Tablet SR and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Voglow 0.3 GM3 SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescription. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Voglow 0.3 GM3 Tablet SR is likely inadvisable. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Voglow 0.3 GM3 Tablet SR presents a likely risk for individuals with kidney impairment and its use should be avoided. Medical advice is recommended. Furthermore, Voglow 0.3 GM3 Tablet SR is contraindicated for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Voglow 0.3 GM3 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Voglow 0.3 GM3 Tablet SR :

Should you forget a Voglow 0.3 GM3 Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Voglow 0.3 GM3 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Voglow 0.3 GM3 Tablet SR

Voglow 0.3 GM3 SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-drug therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Voglow 0.3 GM3 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Voglow 0.3 GM3 Tablet SR is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Voglow 0.3 GM3 Tablet SR and alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglow 0.3 GM3 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Voglow 0.3 GM3 Tablet SR
121
MRP 148
18% off